Relationship between obesity severity and Helicobacter pylori eradication in patients undergoing bariatric and metabolic surgery: A post hoc analysis

Background The global prevalence of obesity is increasing and represents a major public health challenge. However, there is a paucity of data regarding Helicobacter pylori ( H pylori ) eradication in people with obesity. The aim of the study is to examine the influence of obesity degree on H. pylori...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obesity surgery 2024-10, Vol.34 (10), p.3790-3795
Hauptverfasser: Laudanno, Oscar, Ahumarán, Gabriel, Thomé, Marcelo, Gollo, Pablo, Gonzalez, Patricia, Khoury, Marina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3795
container_issue 10
container_start_page 3790
container_title Obesity surgery
container_volume 34
creator Laudanno, Oscar
Ahumarán, Gabriel
Thomé, Marcelo
Gollo, Pablo
Gonzalez, Patricia
Khoury, Marina
description Background The global prevalence of obesity is increasing and represents a major public health challenge. However, there is a paucity of data regarding Helicobacter pylori ( H pylori ) eradication in people with obesity. The aim of the study is to examine the influence of obesity degree on H. pylori eradication in patients undergoing bariatric and metabolic surgery. Methods A post hoc analysis was conducted in a cohort of 204 adults patients (129 individuals diagnosed with obesity, 75 normal weight) H. pylori positive, included in two multicenter, prospective studies. Patients underwent a 14-day quadruple concomitant treatment, and H. pylori eradication was assessed using the 13C-urea breath test. The cohort was stratified according to body mass index (BMI), and statistical analyses were performed using chi-squared test, Kruskal–Wallis test, and logistic regression. Results Eradication rates were significantly lower in patients with obesity compared with normal weight individuals (68.2% vs. 88.0%, OR 0.29, 95% CI 0.13–0.63, p  
doi_str_mv 10.1007/s11695-024-07505-w
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3103450887</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3103450887</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-ff8f7c87c8b1bdb3309d738890604089f1b312491006f5aca7f21879c9788f9f3</originalsourceid><addsrcrecordid>eNp9kc-KFDEQh4Mo7uzqC3iQgBcvrZWk_yTelkXdhQVB9Nwk6cpslp5Om6R36Afxfc3MrAoehEAK8tVXoX6EvGLwjgF07xNjrWoq4HUFXQNNtX9CNqwDWUHN5VOyAdVCJRUXZ-Q8pXsAzlrOn5MzoXhbNw3fkJ9fcdTZhynd-ZkazHvEiQaDyeeVJnzAeCj0NNBrHL0NRtuMkc7rGKKnGPXg7VFA_UTnUuGUE12mAeM2-GlLjY5e5-jtUbLDrE0oIpqWuMW4fqCXdA4p07twIPS4Jp9ekGdOjwlfPt4X5Punj9-urqvbL59vri5vK8ubNlfOSddZWY5hZjBCgBo6IaWCFmqQyjEjGK9V2VbrGm115ziTnbKqk9IpJy7I25N3juHHgin3O58sjqOeMCypFwxE3YCUXUHf_IPehyWW_x4oVrdlhBCF4ifKxpBSRNfP0e90XHsG_SG0_hRaX0Lrj6H1-9L0-lG9mB0Of1p-p1QAcQJSeZrK1v7O_o_2FzgqpUc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3114600633</pqid></control><display><type>article</type><title>Relationship between obesity severity and Helicobacter pylori eradication in patients undergoing bariatric and metabolic surgery: A post hoc analysis</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Laudanno, Oscar ; Ahumarán, Gabriel ; Thomé, Marcelo ; Gollo, Pablo ; Gonzalez, Patricia ; Khoury, Marina</creator><creatorcontrib>Laudanno, Oscar ; Ahumarán, Gabriel ; Thomé, Marcelo ; Gollo, Pablo ; Gonzalez, Patricia ; Khoury, Marina</creatorcontrib><description>Background The global prevalence of obesity is increasing and represents a major public health challenge. However, there is a paucity of data regarding Helicobacter pylori ( H pylori ) eradication in people with obesity. The aim of the study is to examine the influence of obesity degree on H. pylori eradication in patients undergoing bariatric and metabolic surgery. Methods A post hoc analysis was conducted in a cohort of 204 adults patients (129 individuals diagnosed with obesity, 75 normal weight) H. pylori positive, included in two multicenter, prospective studies. Patients underwent a 14-day quadruple concomitant treatment, and H. pylori eradication was assessed using the 13C-urea breath test. The cohort was stratified according to body mass index (BMI), and statistical analyses were performed using chi-squared test, Kruskal–Wallis test, and logistic regression. Results Eradication rates were significantly lower in patients with obesity compared with normal weight individuals (68.2% vs. 88.0%, OR 0.29, 95% CI 0.13–0.63, p  &lt; 0.01). Furthermore, within the population diagnosed with obesity, the degree of obesity correlated with decreased eradication rates, with class 3 (BMI 40.0–49.9) and class 4 (BMI ≥ 50.0) obesity showing the lowest rates (67% and 51%, with an OR 0.28 and 0.15 respectively, p  &lt; 0.01). Conclusions Our results indicate that obesity may influence H. pylori eradication, especially among severe obesity patients undergoing bariatric surgery, which could have implications for the development of ulcers and gastritis as well as the risk of gastric cancer. Tailored eradication strategies may be necessary to improve treatment efficacy in this population.</description><identifier>ISSN: 0960-8923</identifier><identifier>ISSN: 1708-0428</identifier><identifier>EISSN: 1708-0428</identifier><identifier>DOI: 10.1007/s11695-024-07505-w</identifier><identifier>PMID: 39264552</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adult ; Anti-Bacterial Agents - therapeutic use ; Bariatric Surgery ; Body Mass Index ; Breath Tests ; Drug Therapy, Combination ; Female ; Gastrointestinal surgery ; Helicobacter Infections - drug therapy ; Helicobacter pylori ; Humans ; Male ; Medicine ; Medicine &amp; Public Health ; Metabolism ; Middle Aged ; Obesity ; Obesity, Morbid - complications ; Obesity, Morbid - surgery ; Prospective Studies ; Proton Pump Inhibitors - therapeutic use ; Surgery ; Treatment Outcome</subject><ispartof>Obesity surgery, 2024-10, Vol.34 (10), p.3790-3795</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-ff8f7c87c8b1bdb3309d738890604089f1b312491006f5aca7f21879c9788f9f3</cites><orcidid>0000-0002-5817-3292</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11695-024-07505-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11695-024-07505-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39264552$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Laudanno, Oscar</creatorcontrib><creatorcontrib>Ahumarán, Gabriel</creatorcontrib><creatorcontrib>Thomé, Marcelo</creatorcontrib><creatorcontrib>Gollo, Pablo</creatorcontrib><creatorcontrib>Gonzalez, Patricia</creatorcontrib><creatorcontrib>Khoury, Marina</creatorcontrib><title>Relationship between obesity severity and Helicobacter pylori eradication in patients undergoing bariatric and metabolic surgery: A post hoc analysis</title><title>Obesity surgery</title><addtitle>OBES SURG</addtitle><addtitle>Obes Surg</addtitle><description>Background The global prevalence of obesity is increasing and represents a major public health challenge. However, there is a paucity of data regarding Helicobacter pylori ( H pylori ) eradication in people with obesity. The aim of the study is to examine the influence of obesity degree on H. pylori eradication in patients undergoing bariatric and metabolic surgery. Methods A post hoc analysis was conducted in a cohort of 204 adults patients (129 individuals diagnosed with obesity, 75 normal weight) H. pylori positive, included in two multicenter, prospective studies. Patients underwent a 14-day quadruple concomitant treatment, and H. pylori eradication was assessed using the 13C-urea breath test. The cohort was stratified according to body mass index (BMI), and statistical analyses were performed using chi-squared test, Kruskal–Wallis test, and logistic regression. Results Eradication rates were significantly lower in patients with obesity compared with normal weight individuals (68.2% vs. 88.0%, OR 0.29, 95% CI 0.13–0.63, p  &lt; 0.01). Furthermore, within the population diagnosed with obesity, the degree of obesity correlated with decreased eradication rates, with class 3 (BMI 40.0–49.9) and class 4 (BMI ≥ 50.0) obesity showing the lowest rates (67% and 51%, with an OR 0.28 and 0.15 respectively, p  &lt; 0.01). Conclusions Our results indicate that obesity may influence H. pylori eradication, especially among severe obesity patients undergoing bariatric surgery, which could have implications for the development of ulcers and gastritis as well as the risk of gastric cancer. Tailored eradication strategies may be necessary to improve treatment efficacy in this population.</description><subject>Adult</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Bariatric Surgery</subject><subject>Body Mass Index</subject><subject>Breath Tests</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Gastrointestinal surgery</subject><subject>Helicobacter Infections - drug therapy</subject><subject>Helicobacter pylori</subject><subject>Humans</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metabolism</subject><subject>Middle Aged</subject><subject>Obesity</subject><subject>Obesity, Morbid - complications</subject><subject>Obesity, Morbid - surgery</subject><subject>Prospective Studies</subject><subject>Proton Pump Inhibitors - therapeutic use</subject><subject>Surgery</subject><subject>Treatment Outcome</subject><issn>0960-8923</issn><issn>1708-0428</issn><issn>1708-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc-KFDEQh4Mo7uzqC3iQgBcvrZWk_yTelkXdhQVB9Nwk6cpslp5Om6R36Afxfc3MrAoehEAK8tVXoX6EvGLwjgF07xNjrWoq4HUFXQNNtX9CNqwDWUHN5VOyAdVCJRUXZ-Q8pXsAzlrOn5MzoXhbNw3fkJ9fcdTZhynd-ZkazHvEiQaDyeeVJnzAeCj0NNBrHL0NRtuMkc7rGKKnGPXg7VFA_UTnUuGUE12mAeM2-GlLjY5e5-jtUbLDrE0oIpqWuMW4fqCXdA4p07twIPS4Jp9ekGdOjwlfPt4X5Punj9-urqvbL59vri5vK8ubNlfOSddZWY5hZjBCgBo6IaWCFmqQyjEjGK9V2VbrGm115ziTnbKqk9IpJy7I25N3juHHgin3O58sjqOeMCypFwxE3YCUXUHf_IPehyWW_x4oVrdlhBCF4ifKxpBSRNfP0e90XHsG_SG0_hRaX0Lrj6H1-9L0-lG9mB0Of1p-p1QAcQJSeZrK1v7O_o_2FzgqpUc</recordid><startdate>20241001</startdate><enddate>20241001</enddate><creator>Laudanno, Oscar</creator><creator>Ahumarán, Gabriel</creator><creator>Thomé, Marcelo</creator><creator>Gollo, Pablo</creator><creator>Gonzalez, Patricia</creator><creator>Khoury, Marina</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5817-3292</orcidid></search><sort><creationdate>20241001</creationdate><title>Relationship between obesity severity and Helicobacter pylori eradication in patients undergoing bariatric and metabolic surgery: A post hoc analysis</title><author>Laudanno, Oscar ; Ahumarán, Gabriel ; Thomé, Marcelo ; Gollo, Pablo ; Gonzalez, Patricia ; Khoury, Marina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-ff8f7c87c8b1bdb3309d738890604089f1b312491006f5aca7f21879c9788f9f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Bariatric Surgery</topic><topic>Body Mass Index</topic><topic>Breath Tests</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Gastrointestinal surgery</topic><topic>Helicobacter Infections - drug therapy</topic><topic>Helicobacter pylori</topic><topic>Humans</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metabolism</topic><topic>Middle Aged</topic><topic>Obesity</topic><topic>Obesity, Morbid - complications</topic><topic>Obesity, Morbid - surgery</topic><topic>Prospective Studies</topic><topic>Proton Pump Inhibitors - therapeutic use</topic><topic>Surgery</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Laudanno, Oscar</creatorcontrib><creatorcontrib>Ahumarán, Gabriel</creatorcontrib><creatorcontrib>Thomé, Marcelo</creatorcontrib><creatorcontrib>Gollo, Pablo</creatorcontrib><creatorcontrib>Gonzalez, Patricia</creatorcontrib><creatorcontrib>Khoury, Marina</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Obesity surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Laudanno, Oscar</au><au>Ahumarán, Gabriel</au><au>Thomé, Marcelo</au><au>Gollo, Pablo</au><au>Gonzalez, Patricia</au><au>Khoury, Marina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relationship between obesity severity and Helicobacter pylori eradication in patients undergoing bariatric and metabolic surgery: A post hoc analysis</atitle><jtitle>Obesity surgery</jtitle><stitle>OBES SURG</stitle><addtitle>Obes Surg</addtitle><date>2024-10-01</date><risdate>2024</risdate><volume>34</volume><issue>10</issue><spage>3790</spage><epage>3795</epage><pages>3790-3795</pages><issn>0960-8923</issn><issn>1708-0428</issn><eissn>1708-0428</eissn><abstract>Background The global prevalence of obesity is increasing and represents a major public health challenge. However, there is a paucity of data regarding Helicobacter pylori ( H pylori ) eradication in people with obesity. The aim of the study is to examine the influence of obesity degree on H. pylori eradication in patients undergoing bariatric and metabolic surgery. Methods A post hoc analysis was conducted in a cohort of 204 adults patients (129 individuals diagnosed with obesity, 75 normal weight) H. pylori positive, included in two multicenter, prospective studies. Patients underwent a 14-day quadruple concomitant treatment, and H. pylori eradication was assessed using the 13C-urea breath test. The cohort was stratified according to body mass index (BMI), and statistical analyses were performed using chi-squared test, Kruskal–Wallis test, and logistic regression. Results Eradication rates were significantly lower in patients with obesity compared with normal weight individuals (68.2% vs. 88.0%, OR 0.29, 95% CI 0.13–0.63, p  &lt; 0.01). Furthermore, within the population diagnosed with obesity, the degree of obesity correlated with decreased eradication rates, with class 3 (BMI 40.0–49.9) and class 4 (BMI ≥ 50.0) obesity showing the lowest rates (67% and 51%, with an OR 0.28 and 0.15 respectively, p  &lt; 0.01). Conclusions Our results indicate that obesity may influence H. pylori eradication, especially among severe obesity patients undergoing bariatric surgery, which could have implications for the development of ulcers and gastritis as well as the risk of gastric cancer. Tailored eradication strategies may be necessary to improve treatment efficacy in this population.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>39264552</pmid><doi>10.1007/s11695-024-07505-w</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-5817-3292</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0960-8923
ispartof Obesity surgery, 2024-10, Vol.34 (10), p.3790-3795
issn 0960-8923
1708-0428
1708-0428
language eng
recordid cdi_proquest_miscellaneous_3103450887
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Adult
Anti-Bacterial Agents - therapeutic use
Bariatric Surgery
Body Mass Index
Breath Tests
Drug Therapy, Combination
Female
Gastrointestinal surgery
Helicobacter Infections - drug therapy
Helicobacter pylori
Humans
Male
Medicine
Medicine & Public Health
Metabolism
Middle Aged
Obesity
Obesity, Morbid - complications
Obesity, Morbid - surgery
Prospective Studies
Proton Pump Inhibitors - therapeutic use
Surgery
Treatment Outcome
title Relationship between obesity severity and Helicobacter pylori eradication in patients undergoing bariatric and metabolic surgery: A post hoc analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T02%3A43%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relationship%20between%20obesity%20severity%20and%20Helicobacter%20pylori%20eradication%20in%20patients%20undergoing%20bariatric%20and%20metabolic%20surgery:%20A%20post%20hoc%20analysis&rft.jtitle=Obesity%20surgery&rft.au=Laudanno,%20Oscar&rft.date=2024-10-01&rft.volume=34&rft.issue=10&rft.spage=3790&rft.epage=3795&rft.pages=3790-3795&rft.issn=0960-8923&rft.eissn=1708-0428&rft_id=info:doi/10.1007/s11695-024-07505-w&rft_dat=%3Cproquest_cross%3E3103450887%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3114600633&rft_id=info:pmid/39264552&rfr_iscdi=true